News


PreveCeutical Announces Strategic R&D Supply Agreement

September 21st, 2017 - Ryan Allway

September 21, 2017, Vancouver, British Columbia: PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE: PREV, OTCQB: PRVCF, Frankfurt: 18H) is pleased to announce that it has entered into a strategic research and development supply agreement dated effective September 18, 2017 (the “Supply Agreement”) with a licensed producer of medical cannabis (the “LP”) under Health Canada’s Access to […]

Emerald Health Therapeutics’ Scientific Advisors Publish Research Discovery of THCA Cannabinoid’s Neuroprotective Treatment Potential

September 20th, 2017 - Ryan Allway

VICTORIA, British Columbia, Sept. 20, 2017 (GLOBE NEWSWIRE) — Emerald Health Therapeutics Inc. (EHT) (EMH.V) (EMHTF), a Canadian licensed medical producer of cannabis, is pleased to report that members of its scientific advisory team have made a novel discovery highlighting the potential of tetrahydrocannabinolic acid (THCA), a naturally occurring non-psychotropic cannabinoid, to treat Huntington’s disease […]

Cannabis Wheaton Announces Exclusive Distribution Alliance With Independent Pharmacy Group

September 20th, 2017 - Ryan Allway

VANCOUVER, BC–(Marketwired – September 20, 2017) – Cannabis Wheaton Income Corp. (TSX VENTURE: CBW) (“Cannabis Wheaton”, “CW”, or the “Company“) is happy to announce that it has entered an exclusive distribution alliance with the corporate owner of a national chain of independent pharmacies (the “Pharmacy Group“) to develop and implement medical cannabis distribution and retail sale opportunities at all Pharmacy […]

ABcann Global Enters Its Growth Phase (with Exclusive Interview)

September 20th, 2017 - Ryan Allway

Canada’s cannabis industry is expected to reach C$22.6 billion over the coming years, according to Deloitte, as recreational legalization goes into effect next year. Despite about 60 licensed producers approved by Health Canada, the market is expected to experience a shortfall in production that could lead to an opportunity for investors. Licensed producers like ABcann […]

Abattis Prepares for Growth in Extracts

September 20th, 2017 - Ryan Allway

Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte analysts, driven by the legalization of recreational cannabis next year. While many licensed producers are focused on expanding capacity, the best opportunities may be those that can add value for existing licensed producers. These opportunities include those companies focused […]

InMed Pharma: A Leader in Cannabinoid Biosynthesis

September 20th, 2017 - Ryan Allway

The medical cannabis industry is largely focused on only two cannabinoids – tetrahydrocannabinol (THC) and cannabidiol (CBD) – but there are dozens of others (90+) that could have potentially beneficial therapeutic effects. The industry wide problem? These other minor cannabinoids aren’t easily extracted from botanical cannabis sources. Even if they were, they aren’t present in […]

True Leaf: Crowdfunding Legal Cannabis Products Across North America

September 20th, 2017 - Ryan Allway

The North American cannabis industry was worth $6.7 billion in 2016 and is projected to reach $20.2 billion by 2021, according Arcview Market Research, representing a 25% compounded annual growth rate. In addition to federal legalization in Canada, U.S. consumers have become increasingly interested in the potential health benefits of hemp – also known as […]

Saavy Naturals Expands Distribution into Major Retailers

September 20th, 2017 - Ryan Allway

Trimax Corporation’s (OTC Pink: TMXN) wholly-owned subsidiary, Saavy Naturals Inc., has made tremendous progress over the past few months expanding distribution of its all natural body care line, including its Bay Rum and Hemp product offerings, across major retailers around the world. These developments could help accelerate revenue over the coming quarters and move closer […]

United Cannabis: Developing Anti-Inflammatory Pharmaceuticals (Plus Exclusive Interview)

September 20th, 2017 - Ryan Allway

The medical cannabis industry is projected to reach $55.8 billion by 2025, according to Grand View Research, but that figure pales in comparison to the wider pharmaceutical market that’s worth more than $1 trillion per year. Despite the availability of medical marijuana at dispensaries, many people would rather see their primary care physician for treatments […]

Aurora Begins Supplying German Medical Cannabis Market

September 19th, 2017 - Ryan Allway

Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that it has received all the required permits to ship dried cannabis flower from Canada to Germany, enabling the Company to begin supplying the German medical cannabis market through its wholly-owned subsidiary Pedanios GmbH (“Pedanios”). Aurora is now in receipt of […]

Lifestyle Delivery Systems Certificate of Occupancy

September 19th, 2017 - Ryan Allway

VANCOUVER, British Columbia , Sept. 19, 2017 /CNW/ — Lifestyle Delivery Systems Inc. (CSE:LDS), (LDSYF) and ( Frankfurt : LD6, WKN: A14XHT) (“LDS” or the “Company”) announces that on September 14, 2017 , the inspection approval of the CSPA Group’s facility by the fire department of San Bernardino County was submitted to the City of Adelanto […]

InMed Retains Consultant Ben Paterson for Biosynthesis Development

September 19th, 2017 - Ryan Allway

VANCOUVER, Sept. 19, 2017 /PRNewswire/ – InMed Pharmaceuticals, Inc. (“InMed” or the “Company”) (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, announced today that it has retained the consulting services of Ben Paterson, P.E., to assist in defining the pathway for the scale-up, purification, and manufacturing strategies for InMed’s […]

Pivot Pharma Looks to Improve Cannabinoid Bioavailability with Topical BiPhasix™ Delivery System

September 19th, 2017 - Ryan Allway

The global medical cannabis industry is expected to exceed $55 billion in annual sales by 2025, according to Grand View Research, driven by liberal drug laws and increasing interest among consumers, academics and healthcare providers. Early research has shown that cannabinoids, like tetrahydrocannabinol (THC) and cannabidiol (CBD), could treat many medical conditions ranging from chronic […]

Innovative Partnership Forged Between LSU AgCenter And GB Sciences To Advance The Understanding Of The Cannabis Plant

September 18th, 2017 - Ryan Allway

LAS VEGAS, Sept. 18, 2017 /PRNewswire/ — GB Sciences, Inc. (GBLX) announces that Louisiana State University (LSU) AgCenter has signed their agreement with GB Sciences Louisiana, LLC, a wholly-owned subsidiary of GB Sciences, Inc., for the production of medical cannabis products for qualifying patients.  In compliance with the Alison Neustrom Act, GB Sciences will produce medical cannabis under the AgCenter’s […]

Emerald Health Therapeutics Launches Island Mist, One of Canada’s Highest CBD and CBD to THC Ratio Dried Flower Products

September 18th, 2017 - Ryan Allway

VICTORIA, British Columbia, Sept. 18, 2017 (GLOBE NEWSWIRE) — Emerald Health Therapeutics Inc. (Therapeutics) (EMH.V) (EMHTF) has released Island Mist, its proprietary high cannabidiol (CBD) and high CBD to THC ratio dried flower product. This Indica-dominant strain, which came out of Emerald’s broad seed bank through extensive screening and characterization, contains 15.9% CBD and just 0.4% […]

Cannabis Wheaton Announces Launch of Wheaton Licensing Program

September 18th, 2017 - Ryan Allway

VANCOUVER, BC–(Marketwired – September 18, 2017) – Cannabis Wheaton Income Corp. (TSX VENTURE: CBW) (“Cannabis Wheaton”, “CW”, or the “Company“) is excited to announce the launch of Wheaton Licensing, an accelerator platform to support exceptional entrepreneurs through all stages of the application process to become licensed producers of cannabis in Canada. Hugo Alves, President of Cannabis Wheaton, stated, “One […]

Navy Capital’s Green Fund Provides Exposure to the Cannabis Industry

September 18th, 2017 - Ryan Allway

Institutional investors are increasingly looking to build exposure to the cannabis industry into their portfolios. The newly launched Navy Capital Green Fund provides investors with a cannabis-focused portfolio that’s uncorrelated with the overall market. Unlike index funds, the fund is actively managed and focused on acquiring undervalued cannabis companies with strong fundamental and technical profiles. […]

United Cannabis Partners with Releaf Global to Enter Australian Market

September 15th, 2017 - Ryan Allway

Company Grants New Venture Exclusive License To Commercialize Its Patented Prana Line Throughout Australia DENVER, CO / ACCESSWIRE / September 14, 2017 / United Cannabis Corporation (CNAB) (United Cannabis or the “Company”) today announced that it has signed an Agreement with Releaf Global Pty Ltd. (“Releaf”) to form and operate an Australian corporation (“NEWCO”) for the […]

FinCanna Capitalizes on CA’s Burgeoning Cannabis Industry

September 15th, 2017 - Ryan Allway

The U.S. cannabis industry is projected to reach $50 billion by 2026, according to Cowen & Co., driven by the legalization of medicinal and adult use marijuana in several states. Despite these massive growth rates, federal prohibition has prevented large agricultural, pharmaceutical, and tobacco companies from participating in the upside. The flip side of the […]

CureDots™ Look to Redefine How Animal Clinical Trials Are Conducted

September 14th, 2017 - Ryan Allway

Animals are commonly used when testing drugs, vaccines, and biologics to determine the safety of the product before testing them on humans, according to the U.S. Food and Drug Administration. The focus of animal testing is to assess the drug’s nature, chemistry, and effects (pharmacology) and its potential damage to the body (toxicology) by measuring […]

CFN Media Launches New Podcast Series with First Episode Released

September 13th, 2017 - Ryan Allway

CFN Media Group (“CannabisFN”), a leading creative agency and media network serving the global cannabis industry, today announced the debut of its new podcast series, CFN Insider, that provides an insider’s view into the global cannabis industry featuring experts across all markets and segments. “In each episode, CFN Insider will share the most critical and […]

Tilray Receives License to Produce Medical Cannabis in the European Union

September 13th, 2017 - Ryan Allway

Tilray, a global pioneer in medical cannabis research and production, announced plans today to invest up to €20 million in a European Union Campus (EU Campus) after receiving licenses from the Government of Portugal to import cannabis genetics and to cultivate cannabis for medical purposes. “Tilray’s EU Campus is another strategic milestone as we aim […]

Abattis Provides Important Update on Northern Vine and Sales Division

September 13th, 2017 - Ryan Allway

VANCOUVER, British Columbia, Sept. 13, 2017 (GLOBE NEWSWIRE) — Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (ATTBF) is pleased to provide an important update regarding its subsidiaries Northern Vine Canada Inc. (“Northern Vine”) and Vergence Naturals Ltd. (“Vergence”). “We are very pleased with the continued progress being made to strengthen to the sales, marketing and distribution […]

CFN Media Takes a Look into Future Farm’s Cutting-Edge Facility

September 12th, 2017 - Ryan Allway

CFN Media recently published an exclusive video that takes a look into Future Farm Technologies Inc.’s (CSE: FFT) (OTCQB: FFRMF) cutting-edge facility shortly before it harvested its first cannabis crop in California. Watch the complete video here: “The video features our LED Canada line of COB LED grow lights and gives our investors a behind […]

Pivot Pharmaceuticals Acquires BiPhasix™ Transdermal Drug Delivery Technology

September 12th, 2017 - Ryan Allway

Vancouver, British Columbia, Sept. 12, 2017 (GLOBE NEWSWIRE) — Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) (“Pivot” or the “Company”), is pleased to announce that it has signed a Definitive Agreement with Altum Pharmaceuticals Inc., to acquire worldwide rights to BiPhasix™ Transdermal Drug Delivery technology for the development and commercialization of Cannabinoids, Cannabidiol (CBD) and Tetrahydrocannabinol (THC) products. According […]

InMed Files Provisional Patent for Biosynthesis of Cannabinoids

September 12th, 2017 - Ryan Allway

VANCOUVER, Sept. 12, 2017 /PRNewswire/ – InMed Pharmaceuticals, Inc. (“InMed” or the “Company”) (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, today announces the filing of a provisional patent application pertaining to the Company’s proprietary biosynthesis program for the manufacture of cannabinoids that are identical to those found in […]

How to Capitalize on the $1 Billion Hemp Industry

September 11th, 2017 - Ryan Allway

The cannabis industry may be on track to surpass $50 billion by 2026, but that doesn’t mean that investors should ignore the nascent hemp industry. With a projected 55% compound annual growth rate, the hemp industry is projected to surpass $1 billion in just three years. Analysts are bullish on the prospects for the industry, […]

Biosynthesis Could Reduce Regulatory Hurdles for Cannabis Researchers

September 7th, 2017 - Ryan Allway

The medical marijuana movement has made tremendous progress across the United States, but acceptance in the medical community is an entirely different story. While the FDA has approved a handful of drugs containing synthetic cannabinoids, the agency has never approved a product derived from botanical marijuana. Critics argue that synthetic cannabinoids miss the so-called entourage […]

Grow Lights: Why Cannabis Grows Need a Change

September 7th, 2017 - Ryan Allway

The global cannabis grow light market is anticipated to reach $8.64 billion by 2025, according to Grand View Research, growing at a 14.1% compound annual growth rate. Artificial lighting, such as high-pressure sodium lighting, LED lighting, and plasma lighting, extends the hours of natural daylight to increase the health, growth rate, and yield of crops, […]

The Green Organic Dutchman Secures Second Property, 75 Acres Located in Quebec

September 7th, 2017 - Ryan Allway

HAMILTON, ON–(Marketwired – September 07, 2017) – The Green Organic Dutchman Holdings Ltd. (the “Company”) is pleased to announce that it has secured a 75-acre property located in Salaberry-de-Valleyfield, Quebec (the “Quebec Property”). The Company intends to develop the Quebec Property in multiple phases, with Phase 1 construction expected to commence in the fall of 2017. […]


Network Partners

Follow Us on Social Media

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.

Learn How Your Company can Be Covered on CFN Media

Learn More About the CFN Media Sponsored Content Program

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.

Copyright © TDM Financial LLC · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading